Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • BiotechToday
  • World

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

DNA tales September 26, 2023September 25, 2023

Jahnavee Palsodkar, Institute of Bioinformatics and Biotechnology, Savitribai Phule Pune University, Pune, Maharashtra, India

Battling pathogens for healthy fruits

Citrus canker is a pathogenic disease that impacts citrus plants, inducing lesions on various plant organs such as leaves and fruits. This severely diminishes the viability and economic value of the plant. Efforts to cultivate a resistant citrus variety for commercial purposes have been largely unsuccessful, primarily due to the prolonged breeding period and the stringent regulations pertaining to transgenic plants. However, a promising breakthrough has emerged. In their 2023 study, Su et al. introduced a noteworthy development: a transgene-free, canker-resistant strain of Citrus sinensis (commonly known as Orange). Remarkably, they achieved this accomplishment in just 10 months, all while preserving the economically significant phenotype of the wild-type plant.

canker

The pathogen vs. The remedy

Citrus canker arises due to Xanthomonas citri sbsp. citri (hereafter referred to as Xcc). An Xcc-encoded pathogenic element activates the canker-susceptibility gene LOB1 in citrus plants, inducing to the manifestation of citrus canker symptoms. In this study, the researchers used the Cas12aU RNA ribonucleoprotein (RNP) complex to disrupt an exon within the coding sequence of the CsLOB1 gene in the embryogenic protoplasts of C. sinensis. This imparts Xcc resistance to the subsequently regenerated plant.

The strategy

Initially, to assess the efficiency of the RNP system i.e. the LbCas12aU/crRNA complex, the authors performed targeted editing of the CsPDS gene. This gene was chosen due to its easily detectable albino phenotype. The editing efficiency was gauged through in-vitro digestion of the first exon of the CsPDS gene. With successful results, the study progressed to the transformation of embryogenic C. sinensis protoplasts via the PEG method. Embryos exhibiting the albino phenotype were subjected to Sanger sequencing, which unveiled a consistent 9 base pair mutation at the designated site. Based on these positive results, the authors advanced to the targeted mutation of the CsLOB1 gene.

Mechanism

The researchers utilized the crRNA, a component of the guide RNA that is complementary to the target DNA, to specifically target the second exon in the coding region of the CsLOB1 gene. They designed it meticulously to prevent mutations in homologous sites outside of the intended target. They achieved the transformation of embryogenic protoplasts through the utilization of the LbCas12aU/crRNA complex. Out of the 38 lines that survived grafting, 97.4% exhibited homozygous/biallelic mutations. Subsequent NGS analysis uncovered that all lines carried an identical 7-base pair mutation at the specified site and contained no off-target mutations.

Conclusion

Further evaluation of the CsLOB1 mutants showed phenotype of narrower leaves in comparison to the wild-type in 6 out of the 38 lines. This phenomenon can be attributed to somaclonal variations arising due to tissue culture. Infecting these mutants with Xcc did not trigger any canker symptoms. Additionally, the mutants displayed considerably lower Xcc titres compared to the similarly infected wild-type C. sinensis. To study the mechanism behind the Xcc resistance in these mutants, qRT-PCR analysis was conducted on genes recognized to be upregulated by LOB1 during Xcc infections. The findings showcased a notably reduced expression of these genes as compared with the wild-type, indicating that the mutation in the LOB1 gene had effectively halted the activation of downstream genes responsible for causing citrus canker.

Summary

To recapitulate, Su et al. successfully developed an Xcc-resistant version of Citrus sinensis utilizing the transgene-free RNP technique. This variety is devoid of any off-target mutations or foreign genetic elements, and it presents no discernible deviations from the wild-type strains apart from its heightened resistance to canker. These attributes played a pivotal role in securing it a regulatory endorsement from the USDA APHIS (Animal and Plant Health Inspection Service), marking a significant milestone in overcoming a crucial barrier towards its viable commercial deployment.

Also Read: AI Literacy in Early Childhood Education: Challenges and Opportunities

Reference:

Su, H., Wang, Y., Xu, J. et al. Generation of the transgene-free canker-resistant Citrus sinensis using Cas12a/crRNA ribonucleoprotein in the T0 generation. Nat Commun 14, 3957 (2023). https://doi.org/10.1038/s41467-023-39714-9

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Cas12aU RNP Complex Citrus Canker Resistance CRISPR-Cas12a crop improvement CsLOB1 Gene Disruption Embryogenic Protoplasts Exon Disruption Gene knockout Gene Targeting Genome editing Guide RNA Design Homology-Directed Repair plant biotechnology Protoplast Transformation Transgene-Free Citrus sinensis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Cell Senescence in Type II Diabetes: Therapeutic Potential

DNA tales September 28, 2023

Snata Pandey, St. Xavier’s College (Autonomous), Kolkata The dark side of cell cycle Cell senescence is a permanent arrest of the cycle of a damaged or stressed cell, at either the gap 1 (G1) or the gap 2 (G2) phase. Senescence starts during embryogenesis, occurs throughout life, but senescent cells are regularly cleared by the […]

senescence

Related Post

  • BiotechToday
  • India

First Cadaveric Liver Transplantation in India by HOPE pump

BioTech Today June 28, 2021June 27, 2021

Shrestha Dutta, Amity University Kolkata What is Cadaveric liver transplantation? The patients who need a liver transfer yet do not have a living-related donor are offered the choice of Deceased Donor Liver Transplant (DDLT) also known as Cadaver Liver transfer. What is HOPE? Hypothermic oxygenated machine perfusion (HOPE) was presented in liver transplantation (LT) to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Cancer Vaccines: A Concoction Strategy to fight Leukemia

bioxone October 15, 2020October 15, 2020

Chitra Roy, University of Calcutta Leukemia is a malignancy of blood cells that starts to develop when the DNA of a single cell in the bone marrow mutates and fails to develop and function properly. These leukemia cells crowd out normal blood cells, making it difficult for the normal cells to do their job. Chronic […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Posaconazole: An aid against fungal infections

bioxone May 26, 2021May 25, 2021

Saptaparna Pal, Amity University Kolkata Posaconazole is the latest antifungal agent to be approved for use in Canada against severe fungal infections. With excellent and intensive activity against a large spectrum of fungi as well as yeasts, as well as having a well-formulated oral formulation, posaconazole provides many possible advantages. Amphotericin B, whether in lipid-based […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy